|
|
|
Insider
Information: |
Geraghty James A |
Relationship: |
|
City: |
Framingham |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
311,097 |
|
Indirect Shares
|
138 |
|
|
Direct
Value |
$689,137 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
311,235 |
|
|
Total
Value |
$689,137 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
GTC Biotherapeutics Inc |
GTCB |
Director |
2009-12-31 |
19,025 |
2009-12-31 |
138 |
Premium* |
|
Genzyme Corp |
GENZ |
Senior Vice President |
2011-04-04 |
0 |
2011-04-04 |
0 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
2021-01-04 |
104,770 |
2013-08-19 |
0 |
Premium* |
|
Juniper Pharmaceuticals Inc |
JNP |
Director |
2018-08-14 |
0 |
2015-05-26 |
0 |
Premium* |
|
Voyager Therapeutics, Inc. |
VYGR |
Director |
2018-09-10 |
76,588 |
|
0 |
Premium* |
|
Pieris Pharmaceuticals, Inc. |
PIRS |
|
2018-05-15 |
20,000 |
2017-08-17 |
0 |
Premium* |
|
Fulcrum Therapeutics, Inc. |
FULC |
Director |
2021-06-28 |
90,714 |
|
0 |
Premium* |
|
Orchard Therapeutics Plc |
ORTX |
|
2024-01-24 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACGN |
Aceragen, Inc |
Director |
|
2018-07-02 |
4 |
A |
$1.32 |
$10,687 |
D/D |
8,096 |
443,465 |
0 |
- |
|
ACGN |
Aceragen, Inc |
Director |
|
2016-07-01 |
4 |
A |
$1.63 |
$15,844 |
D/D |
9,720 |
435,369 |
0 |
- |
|
ACGN |
Aceragen, Inc |
Director |
|
2016-05-13 |
4 |
B |
$1.34 |
$13,400 |
D/D |
10,000 |
425,649 |
2.39 |
- |
|
ACGN |
Aceragen, Inc |
Director |
|
2015-04-01 |
4 |
A |
$3.52 |
$10,560 |
D/D |
3,000 |
415,649 |
0 |
- |
|
ACGN |
Aceragen, Inc |
Director |
|
2014-05-27 |
4 |
B |
$2.65 |
$26,500 |
D/D |
10,000 |
412,649 |
2.39 |
- |
|
ACGN |
Aceragen, Inc |
Director |
|
2014-04-01 |
4 |
A |
$4.41 |
$7,215 |
D/D |
1,636 |
402,649 |
0 |
- |
|
ACGN |
Aceragen, Inc |
Director |
|
2014-01-02 |
4 |
A |
$4.75 |
$4,812 |
D/D |
1,013 |
401,013 |
0 |
- |
|
ACGN |
Aceragen, Inc |
Director |
|
2013-12-06 |
4 |
B |
$2.72 |
$108,800 |
D/D |
40,000 |
400,000 |
2.39 |
- |
|
ACGN |
Aceragen, Inc |
Director |
|
2013-09-16 |
4 |
B |
$1.90 |
$114,000 |
D/D |
60,000 |
360,000 |
2.39 |
- |
|
ACGN |
Aceragen, Inc |
Director |
|
2013-08-19 |
4 |
B |
$1.75 |
$525,000 |
D/D |
300,000 |
300,000 |
2.39 |
- |
|
GTCB |
GTC Biotherapeutics Inc |
Director |
|
2009-03-27 |
4 |
A |
$0.33 |
$2,750 |
D/D |
8,333 |
124,426 |
0 |
- |
|
GTCB |
GTC Biotherapeutics Inc |
Director |
|
2008-12-26 |
4 |
A |
$0.28 |
$2,750 |
D/D |
9,874 |
116,093 |
0 |
- |
|
GTCB |
GTC Biotherapeutics Inc |
Director |
|
2008-09-26 |
4 |
A |
$0.37 |
$2,750 |
D/D |
7,432 |
106,219 |
0 |
- |
|
ACGN |
Aceragen, Inc |
Director |
|
2021-01-04 |
4 |
A |
$4.02 |
$19,501 |
D/D |
4,851 |
104,770 |
0 |
- |
|
ACGN |
Aceragen, Inc |
Director |
|
2020-10-01 |
4 |
A |
$2.25 |
$19,499 |
D/D |
8,666 |
99,919 |
0 |
- |
|
GTCB |
GTC Biotherapeutics Inc |
Director |
|
2008-06-27 |
4 |
A |
$0.40 |
$2,750 |
D/D |
6,841 |
98,787 |
0 |
- |
|
GTCB |
GTC Biotherapeutics Inc |
Director |
|
2008-03-28 |
4 |
A |
$0.55 |
$2,750 |
D/D |
5,000 |
91,946 |
0 |
- |
|
ACGN |
Aceragen, Inc |
Director |
|
2020-07-01 |
4 |
A |
$1.79 |
$19,500 |
D/D |
10,894 |
91,253 |
0 |
- |
|
FULC |
Fulcrum Therapeutics, Inc... |
Director |
|
2021-06-28 |
4 |
B |
$9.16 |
$91,600 |
D/D |
10,000 |
90,714 |
2.39 |
- |
|
GTCB |
GTC Biotherapeutics Inc |
Director |
|
2007-12-28 |
4 |
A |
$0.87 |
$2,750 |
D/D |
3,161 |
86,946 |
0 |
- |
|
GTCB |
GTC Biotherapeutics Inc |
Director |
|
2007-12-14 |
4 |
B |
$0.87 |
$8,696 |
D/D |
10,000 |
83,785 |
2.39 |
- |
|
FULC |
Fulcrum Therapeutics, Inc... |
Director |
|
2019-07-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
80,714 |
|
- |
|
ACGN |
Aceragen, Inc |
Director |
|
2020-04-01 |
4 |
A |
$1.28 |
$19,105 |
D/D |
14,926 |
80,359 |
0 |
- |
|
VYGR |
Voyager Therapeutics, Inc... |
Director |
|
2018-09-10 |
4 |
B |
$19.39 |
$58,170 |
D/D |
3,000 |
76,588 |
2.39 |
- |
|
GTCB |
GTC Biotherapeutics Inc |
Director |
|
2007-09-28 |
4 |
A |
$1.02 |
$2,750 |
D/D |
2,696 |
73,785 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|